Michael Thomas Heffernan - Dec 19, 2022 Form 4 Insider Report for COLLEGIUM PHARMACEUTICAL, INC (COLL)

Role
Director
Signature
/s/ Colleen Tupper as Attorney-In-Fact For Michael T. Heffernan
Stock symbol
COLL
Transactions as of
Dec 19, 2022
Transactions value $
-$583,124
Form type
4
Date filed
12/21/2022, 06:28 PM
Previous filing
Dec 14, 2022
Next filing
Dec 27, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction COLL Common Stock Options Exercise $58.2K +3.61K +12.87% $16.15 31.6K Dec 19, 2022 Direct
transaction COLL Common Stock Sale -$83.1K -3.61K -11.4% $23.04 28K Dec 19, 2022 Direct F1, F2
transaction COLL Common Stock Options Exercise $545K +33.8K +120.47% $16.15 61.8K Dec 20, 2022 Direct
transaction COLL Common Stock Sale -$779K -33.8K -54.64% $23.08 28K Dec 20, 2022 Direct F1, F3
transaction COLL Common Stock Options Exercise $753K +46.6K +166.29% $16.15 74.6K Dec 21, 2022 Direct
transaction COLL Common Stock Sale -$1.08M -46.6K -62.45% $23.11 28K Dec 21, 2022 Direct F1, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction COLL Stock Option (Right to Purchase) Options Exercise $0 -3.61K -3.31% $0.00 105K Dec 19, 2022 Common Stock 3.61K $16.15 Direct F5
transaction COLL Stock Option (Right to Purchase) Options Exercise $0 -33.8K -32.03% $0.00 71.6K Dec 20, 2022 Common Stock 33.8K $16.15 Direct F5
transaction COLL Stock Option (Right to Purchase) Options Exercise $0 -46.6K -65.05% $0.00 25K Dec 21, 2022 Common Stock 46.6K $16.15 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2022.
F2 The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.00 to $23.11, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2).
F3 The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.00 to $23.33, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3).
F4 The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.00 to $23.40, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4).
F5 The option, initially representing a right to purchase a total of 109,005 shares, is fully vested and exercisable.